About
Xavier Jacq is a biotech drug-discovery executive and scientist focused on ubiquitin biology, small-molecule discovery, mitochondrial biology, and related therapeutic areas. He co-founded Mission Therapeutics and later held senior scientific roles at Almac Discovery, Dunad Therapeutics, and Moa Technology. On May 1, 2025, MitoRx Therapeutics announced his appointment as Chief Scientific Officer.
Areas of interest
biotechdrug discoverydeubiquitinase biologyubiquitin proteasome systemoncologymetabolismimmunologyCNS therapeuticsmitochondrial biologyobesityagingdegenerative diseasesagritechherbicide discovery